# 2003/896/EC: Commission Decision of 19 December 2003 allowing Member States to extend provisional authorisations granted for the new active substances thiacloprid, thiametoxam, quinoxyfen, flazasulfuron, Spodoptera exigua nuclear polyhedrosis virus, spinosad, Giocladium catenulatum, Pseudomonas chlororaphis and indoxacarb (Text with EEA relevance) (notified under document number C(2003) 4851) (revoked)

EU Decision 2003/896 · adopted 19 December 2003

## Introductory text

2003/896/EC: Commission Decision
of 19 December 2003 allowing Member States to extend provisional authorisations granted for the new active substances thiacloprid, thiametoxam, quinoxyfen, flazasulfuron, Spodoptera exigua nuclear polyhedrosis virus, spinosad, Giocladium catenulatum, Pseudomonas chlororaphis and indoxacarb (Text with EEA relevance) (notified under document number C(2003) 4851) (revoked)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## Articles 

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

---
Source: https://www.legislation.gov.uk/eudn/2003/896 (the official version)
Page: https://openlegislation.uk/eu-decision-2003-896
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.